Table 2.
One-way ANCOVA of the AUC for local metrics.
| Metrics | Region | pAH | non-pAH | HC | F | p |
|---|---|---|---|---|---|---|
| Ne | SFGmed.L | 0.126 ± 0.034* | 0.118 ± 0.034* | 0.139 ± 0.027 | 8.69 | 2.33 × 10−4 |
| Ne | TPOsup.L | 0.124 ± 0.034*,# | 0.139 ± 0.023 | 0.136 ± 0.030 | 8.88 | 1.97 × 10−4 |
| Ne | INS.R | 0.110 ± 0.043*,# | 0.125 ± 0.037 | 0.137 ± 0.030 | 11.53 | 1.74 × 10−5 |
| DC | INS.R | 6.132 ± 3.583*,# | 7.528 ± 3.524 | 8.506 ± 2.897 | 10.92 | 3.03 × 10−5 |
Ne nodal efficiency, DC degree centrality.
The p values for main effects of one-way ANCOVA were shown. For nodal efficiency, the p threshold for surviving the FDR correction was 2.33 × 10−4. For degree centrality, the p threshold for surviving the FDR correction was 3.03 × 10−5. Age, sex, and years of education were set as covariates for ANCOVA. PANSS-POS, PANSS-NEG, PANSS-GPS, and chlorpromazine equivalent dosage were set as covariates for post hoc tests when comparing the pAH group and the non-pAH group.
*p < 0.05 compared with the HC group; #p < 0.05 compared with the non-pAH group.